Your browser doesn't support javascript.
loading
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.
Kulkarni, Prasad S; Padmapriyadarsini, Chandrasekaran; Vekemans, Johan; Bavdekar, Ashish; Gupta, Madhu; Kulkarni, Praveen; Garg, B S; Gogtay, Nithya J; Tambe, Muralidhar; Lalwani, Sanjay; Singh, Kiranjit; Munshi, Renuka; Meshram, Sushant; Selvavinayagam, T S; Pandey, Krishna; Bhimarasetty, Devi Madhavi; Ramakrishnan, S R; Bhamare, Chetanraj; Dharmadhikari, Abhijeet; Vadakkedath, Rajeev; Bonhomme, Cyrille J; Thakar, Madhuri; Kurle, Swarali N; Kelly, Elizabeth J; Gautam, Manish; Gupta, Nivedita; Panda, Samiran; Bhargava, Balram; Shaligram, Umesh; Kapse, Dhananjay; Gunale, Bhagwat.
Affiliation
  • Kulkarni PS; Serum Institute of India Pvt Ltd, Pune, India.
  • Padmapriyadarsini C; Indian Council of Medical Research, Delhi, India.
  • Vekemans J; Clinical Development, Infection, Late-stage Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Bavdekar A; KEM Hospital Research Centre, Vadu Budruk, Pune, India.
  • Gupta M; Post Graduate Institute of Medical Education & Research, Chandigarh, India.
  • Kulkarni P; JSS Academy of Higher Education and Research, Mysore, India.
  • Garg BS; Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha, India.
  • Gogtay NJ; Seth G S Medical College & KEM Hospital, Mumbai, India.
  • Tambe M; B J Government Medical College and Sassoon General Hospitals, Pune, India.
  • Lalwani S; Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, India.
  • Singh K; Jehangir Clinical Development Centre Pvt Ltd, Pune, India.
  • Munshi R; TN Medical College & BYL Nair Hospital, Mumbai, India.
  • Meshram S; Government Medical College, Nagpur, India.
  • Selvavinayagam TS; Directorate of Public Health and Preventive Medicine, Chennai, India.
  • Pandey K; Rajendra Memorial Research Institute of Medical Sciences, Patna, India.
  • Bhimarasetty DM; Andhra Medical College, Visakhapatnam, India.
  • Ramakrishnan SR; Sri Ramchandra Institute of Higher Education and Research, Chennai, India.
  • Bhamare C; Serum Institute of India Pvt Ltd, Pune, India.
  • Dharmadhikari A; Serum Institute of India Pvt Ltd, Pune, India.
  • Vadakkedath R; PPD India Pvt Ltd, Mumbai, India.
  • Bonhomme CJ; Vaccine Sciences Department, PPD® Laboratories Inc., Richmond, VA, USA.
  • Thakar M; Indian Council of Medical Research, Delhi, India.
  • Kurle SN; Indian Council of Medical Research, Delhi, India.
  • Kelly EJ; Translational Medicine, Microbial Sciences, AstraZeneca, Gaithersburg, MD, USA.
  • Gautam M; Serum Institute of India Pvt Ltd, Pune, India.
  • Gupta N; Indian Council of Medical Research, Delhi, India.
  • Panda S; Indian Council of Medical Research, Delhi, India.
  • Bhargava B; Indian Council of Medical Research, Delhi, India.
  • Shaligram U; Serum Institute of India Pvt Ltd, Pune, India.
  • Kapse D; Serum Institute of India Pvt Ltd, Pune, India.
  • Gunale B; Serum Institute of India Pvt Ltd, Pune, India.
EClinicalMedicine ; 42: 101218, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34870133
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: EClinicalMedicine Year: 2021 Document type: Article Affiliation country: India Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: EClinicalMedicine Year: 2021 Document type: Article Affiliation country: India Country of publication: Reino Unido